Share class
Morningstar Rating
Bloomberg Ticker
UEEURIX SW
NAV
2153.4
23.04.2026
YTD
3.55%
as of 23.04.2026
3M
0.70%
as of 23.04.2026
1Y
19.82%
as of 23.04.2026
Share Class name
UBS (CH) Institutional Fund - Equities Europe ex CH Index NSL I-X-acc
Overview
Regulation / Supervision: CISA / FINMA (Funds for qualified investors)
Authorised investors: pension funds, insurance companies, family offices and institutional investors under CISA
Investments: Equity securities issued by European companies listed in the MSCI Europe ex Switzerland Index
No investments in securities on the recommendation list for the exclusion of SVVK-ASIR (www.svvk-asir.ch) and controversial weapons.
Portfolio is passively managed and aims to replicate the performance of the benchmark
Currency exposure: in line with securities portfolio
Securities lending: not permitted
Use of derivatives: permitted under BVV2
Risks
All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. Please consult your client advisor for more information on the investment risks of this product.
Features
| Product category |
Equity Europe |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
June 16, 2011
|
| Currency of account |
CHF
|
| Close of financial year |
October 31
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Next distribution |
January
|
| Maturity |
Open end
|
| Flat fee |
0.00% p.a.
|
| Total expense ratio (TER) |
0.01% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe ex Switzerland (net div reinv.)
|
| Cut-Off Time |
14:00h(CET)
|
| Securities no. |
12512217
|
| ISIN |
CH0125122173
|
| Bloomberg Ticker |
UEEURIX SW
|
| Telekurs Id |
IEEPIIX
|
Performance and Prices
Percentage growth
as of April 23, 2026
Cumulative
| CHF(%) | EUR(%) | USD(%) | |
| YTD | 3.55 | 4.99 | 4.69 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 19.24 | 20.26 | 36.40 |
| 3Y | |||
| 5Y | 38.95 | 67.28 | 62.58 |
| ø p.a.5Y | 6.80 | 10.84 | 10.21 |
Current data
| Net asset value | 23.04.2026 | CHF 2,153.40 |
| High - last 12 months | 17.04.2026 | CHF 2,201.25 |
| Low - last 12 months | 24.04.2025 | CHF 1,821.63 |
| Assets of the unit class in mn | 23.04.2026 | CHF 2,310.71 |
| Total product assets in mn | 23.04.2026 | CHF 2,428.87 |
Statistical data
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 9.56% | 13.14% |
| Sharpe Ratio | 31.03.2026 | 0.70 | 0.45 |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By detailed securities (in %, as of February 27, 2026)*
|
|
|
| UBS Lux Institutional Fund - Equities Europe EX UK EX Switzerland Pass | 73.27 |
| UBS (CH) Institutional Fund - Equities UK Index NSL | 26.76 |
| Iberdrola SA | 0.00 |
| NMC Health PLC | 0.00 |
Fees
Portfolio management fees
0.0000%
Admin/Custodian fees
0.0000%
Distributions
No distributions. Continuous reinvestment of income.
Sales Authorisations
Literature
Brochures
Agreement / Prospectus
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
Annual and semi-annual report (accounting on October 31)
|
Document type
|
Document Language
|
|
| Annual report |
|
|
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.